col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Ovid: Journal of the American Heart Association
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―29 Renin-Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID-19 Jordan Loader, Erik Lampa, Stefan Gustafsson, Thomas Cars, Johan Sundström
2 [GO] 2021―Jul―03 Age and Acute Ischemic Stroke Outcome in North American Patients With COVID-19 Adam A. Dmytriw, Mahmoud Dibas, Clemens M. Schirmer, Fabio Settecase, Manraj K. S. Heran, Aslan Efendizade, et al. (+28)
3 [GO] 2021―Jun―10 Association of Kidney Disease With Outcomes in COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry Anjali Rao, Sagar Ranka, Colby Ayers, Nicholas Hendren, Anna Rosenblatt, Heather M. Alger, et al. (+9)
4 [GO] 2021―Jun―05 Chronic Cardio-Metabolic Disease Increases the Risk of Worse Outcomes Among Hospitalized Patients With COVID-19: A Multicenter, Retrospective, and Real-World Study Qijian Chen, Lingling Wang, Chang Li, Weihua Hu, Yameng Fan, Zaishu Chen, et al. (+8)
5 [GO] 2021―Jun―01 Emergency Medical Services Responses to Out-of-Hospital Cardiac Arrest and Suspected ST-Segment-Elevation Myocardial Infarction During the COVID-19 Pandemic in Los Angeles County Jeffrey Eric Rollman, Robert A. Kloner, Nichole Bosson, James T. Niemann, Marianne Gausche-Hill, Michelle Williams, et al. (+5)
6 [GO] 2021―Jun―01 Death by COVID-19: An Open Investigation Thomas Rea, Peter J. Kudenchuk
7 [GO] 2021―May―28 Implantable Cardioverter-Defibrillator Shocks During COVID-19 Outbreak Selçuk Adabag, Patrick Zimmerman, Adam Black, Mohammad Madjid, Payam Safavi-Naeini, Alan Cheng
8 [GO] 2021―May―19 Inequities in Hypertension Control in the United States Exposed and Exacerbated by COVID-19 and the Role of Home Blood Pressure and Virtual Health Care During and After the COVID-19 Pandemic Adam P. Bress, Jordana B. Cohen, David Edmund Anstey, Molly B. Conroy, Keith C. Ferdinand, Valy Fontil, et al. (+11)
9 [GO] 2021―Mar―18 Correction to: Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis
10 [GO] 2021―Feb―25 Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis Meghan O’Hearn, Junxiu Liu, Frederick Cudhea, Renata Micha, Dariush Mozaffarian
11 [GO] 2021―Feb―24 Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19 Rohan Khera, Callahan Clark, Yuan Lu, Yinglong Guo, Sheng Ren, Brandon Truax, et al. (+6)
12 [GO] 2021―Feb―23 Gender Differences in Publication Authorship During COVID-19: A Bibliometric Analysis of High-Impact Cardiology Journals Ersilia M. DeFilippis, Lauren Sinnenberg, Nadim Mahmud, Malissa J. Wood, Sharonne N. Hayes, Erin D. Michos, Nosheen Reza
13 [GO] 2021―Feb―23 Clinical Application of Serologic Testing for Coronavirus Disease 2019 in Contemporary Cardiovascular Practice Abdulla A. Damluji, Robert H. Christenson, Christopher deFilippi
14 [GO] 2021―Feb―18 SARS-CoV-2 viremia is associated with inflammatory, but not cardiovascular biomarkers, in patients hospitalized for COVID-19 Peder L. Myhre, Christian Prebensen, Christine Monceyron Jonassen, Jan Erik Berdal, Torbjørn Omland
15 [GO] 2021―Feb―08 Anticoagulation prior to hospitalization is a potential protective factor for COVID-19: insight from a French multicenter cohort study Richard Chocron, Vincent Galand, Joffrey Cellier, Nicolas Gendron, Thibaut Pommier, Olivier Bory, et al. (+29)
16 [GO] 2020―Dec―21 Value of Registries in ST-Segment-Elevation Myocardial Infarction Care in Both the Pre-Coronavirus Disease 2019 and the Coronavirus Disease 2019 Eras Ralph G. Brindis, Eric R. Bates, Timothy D. Henry
17 [GO] 2020―Dec―14 Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824,650 Patients with Hypertension from a US integrated Healthcare System Jaejin An, Rong Wei, Hui Zhou, Tiffany Q. Luong, Michael K. Gould, Matthew T. Mefford, et al. (+8)
18 [GO] 2020―Dec―03 Experiences and Beliefs of Low-Income Patients with Hypertension in Louisiana and Mississippi during the COVID-19 Pandemic Katherine T. Mills, Erin Peacock, Jing Chen, Amanda Zimmerman, Hua He, Alecia Cyprian, et al. (+11)
19 [GO] 2020―Nov―24 COVID-19 Associated Thrombosis and Coagulopathy: Review of the Pathophysiology and Implications for Antithrombotic Management Luis Ortega-Paz, Davide Capodanno, Gilles Montalescot, Dominick J Angiolillo
20 [GO] 2020―Nov―10 Admission cardiac diagnostic testing with electrocardiography and troponin measurement prognosticates increased 30-day mortality in COVID-19 Timothy J Poterucha, Pierre Elias, Sneha S. Jain, Gabriel Sayer, Bjorn Redfors, Daniel Burkhoff, et al. (+24)
21 [GO] 2020―Oct―30 Troponin and Other Biomarker Levels and Outcomes Among Patients Hospitalized with COVID-19: Derivation and Validation of the HA 2 T 2 COVID-19 Mortality Risk Score Kevin K. Manocha, Jared Kirzner, Xiaohan Ying, Ilhwan Yeo, Bradley Peltzer, Bryan Ang, et al. (+5)
22 [GO] 2020―Oct―23 Statin Use and In-Hospital Mortality in Diabetics with COVID-19 Omar Saeed, Francesco Castagna, Ilir Agalliu, Xiaonan Xue, Snehal R. Patel, Yogita Rochlani, et al. (+7)
23 [GO] 2020―Oct―14 The Impact of Coronavirus disease 2019 (COVID-19) on Patients with Congenital Heart Disease across the Lifespan: The Experience of an Academic Congenital Heart Disease Center in New York City Matthew J Lewis, Brett R Anderson, Michael Fremed, Melissa Argenio, Usha Krishnan, Rachel Weller, et al. (+9)
24 [GO] 2020―Oct―07 Antecedent Administration of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for SARS-CoV-2 (COVID-19) Alberto Palazzuoli, Massimo Mancone, Gaetano M. De Ferrari, Giovanni Forleo, Gioel G. Secco, Gaetano M Ruocco, et al. (+16)
25 [GO] 2020―Oct―07 Impact of COVID19 Pandemic on the Incidence and Management of Out of Hospital Cardiac Arrest in Patients Presenting with Acute Myocardial Infarction in England Muhammad Rashid, Chris P Gale, Nick Curzen, Peter Ludman, Mark De Belder, Adam Timmis, et al. (+10)
26 [GO] 2020―Sep―30 Cardiovascular clinical trials in the era of a pandemic George CM Siontis, Romy Sweda, Stephan Windecker
27 [GO] 2020―Sep―29 Restarting Human Participant Research at Community-based Observational Studies during the COVID-19 Pandemic Raghava S. Velagaleti, Ramachandran S. Vasan
28 [GO] 2020―Sep―25 High prevalence of acquired thrombophilia without prognosis value in Covid-19 patients Emile Ferrari, Benjamin Sartre, Fabien Squara, Julie Contenti, Celine Occelli, Fabien Lemoel, et al. (+15)
29 [GO] 2020―Sep―22 Cardiac Abnormalities Seen in Pediatric Patients During the SARS-CoV2 Pandemic: An International Experience Bradley C. Clark, Joan Sanchez-de-Toledo, Carles Bautista-Rodriguez, Nadine Choueiter, Diego Lara, Hechaan Kang, et al. (+13)
30 [GO] 2020―Sep―09 Who has seen ST-segment elevation myocardial infarction patients? First results from Italian real world COVID-19 Valeria Cammalleri, Saverio Muscoli, Daniela Benedetto, Giuseppe Stifano, Massimiliano Macrini, Alessio Di Landro, et al. (+10)
31 [GO] 2020―Aug―18 Clinical Characteristics and Risk Factors of Cardiac Involvement in COVID-19 Huayan Xu, Keke Hou, Rong Xu, Zhenlin Li, Hang Fu, Lingyi Wen, et al. (+7)
32 [GO] 2020―Aug―18 Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients Chen Chen, Feng Wang, Peng Chen, Jiangang Jiang, Guanglin Cui, Ning Zhou, et al. (+4)
33 [GO] 2020―Aug―14 Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering from Coronavirus Disease in Wuhan, China Yudong Peng, Kai Meng, Meian He, Ruirui Zhu, Hongquan Guan, Zihan Ke, et al. (+10)
34 [GO] 2020―Aug―05 Correction to: Guidance on Short-Term Management of Atrial Fibrillation in Coronavirus Disease 2019
35 [GO] 2020―Jul―27 The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19 Senthil Selvaraj, Stephen J. Greene, Sameed Ahmed M. Khatana, Ashwin S. Nathan, Scott D. Solomon, Deepak L. Bhatt
36 [GO] 2020―Jul―27 Cardio-Oncology in Era of the COVID-19 Pandemic and Beyond Daniel Addison, Courtney M. Campbell, Avirup Guha, Arjun K. Ghosh, Susan F. Dent, Hani Jneid
37 [GO] 2020―Jul―17 Coronavirus 2019 Disease (COVID-19), Systemic Inflammation, and Cardiovascular Disease Riccardo M. Inciardi, Scott D. Solomon, Paul M. Ridker, Marco Metra
38 [GO] 2020―Jul―15 The prevalence of cardiovascular comorbidities in COVID-19, SARS and MERS: pooled analysis of published data Yang Liu, Shaohui Wu, Mu Qin, Weifeng Jiang, Xu Liu
39 [GO] 2020―Jul―07 Could anti-hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID-19 infection? Data from centers of southern Italy Celestino Sardu, Paolo Maggi, Vincenzo Messina, Pasquale Iuliano, Antonio Sardu, Vincenzo Iovinella, et al. (+2)
40 [GO] 2020―Jun―30 Retrospective Study of Risk Factors for Myocardial Damage in Patients with Critical Coronavirus Disease 2019, in Wuhan Lingzhi Li, Shudi Zhang, Bing He, Xiaobei Chen, Qingyan Zhao
41 [GO] 2020―Jun―18 Perspectives on Cardiopulmonary Critical Care for COVID-19 Patients: From Members of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation Bradley A. Maron, Mark T. Gladwin, Sebastien Bonnet, Vinicio De Jesus Perez, Sarah M. Perman, Paul B. Yu, Fumito Ichinose
42 [GO] 2020―Jun―09 Guidance on Acute Management of Atrial Fibrillation in COVID-19 Pattara Rattanawong, Win Shen, Hicham El Masry, Dan Sorajja, Komandoor Srivathsan, Arturo Valverde, Luis R. Scott
43 [GO] 2020―Jun―09 Coronavirus Disease 2019 (COVID-19) Catheterization Laboratory Survey Subhash Banerjee, Giuseppe Tarantini, Mazen Abu-Fadel, Avantika Banerjee, Bertis B. Little, Paul Sorajja, et al. (+2)
44 [GO] 2020―Jun―01 Strategic Deployment of Cardiology Fellows-in-Training Using the Accreditation Council for Graduate Medical Education COVID-19 Framework Michael J. Gallagher, Richard Bloomingdale, Aaron D. Berman, Brian D. Williamson, Simon R. Dixon, Robert D. Safian
45 [GO] 2020―May―28 Experience with Hydroxychloroquine and Azithromycin in the COVID-19 Pandemic: Implications for QT Interval Monitoring Archana Ramireddy, Harpriya Chugh, Kyndaron Reinier, Joseph Ebinger, Eunice Park, Michael Thompson, et al. (+5)
46 [GO] 2020―May―28 Chloroquine or Hydroxychloroquine for COVID-19: Is Cardiotoxicity a Concern? Timothy J. Kamp, Mohamed H. Hamdan, Craig T. January
47 [GO] 2020―May―26 Transcatheter Aortic Valve Replacement in the Coronavirus Disease 2019 (COVID-19) Era Amgad Mentias, Hani Jneid
48 [GO] 2020―May―22 Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease Tarek Alsaied, Jamil A. Aboulhosn, Timothy B. Cotts, Curt J. Daniels, Susan P. Etheridge, Timothy F. Feltes, et al. (+4)
49 [GO] 2020―May―22 Unpredictable Fall of Severe Emergent Cardiovascular Diseases Hospital Admissions During the COVID-19 Pandemic: Experience of a Single Large Center in Northern Italy Mauro Toniolo, Francesco Negri, Marco Antonutti, Marco Masè, Domenico Facchin
50 [GO] 2020―May―16 Cardiac Surgery during the COVID-19 Pandemic: Perioperative Considerations and Triage Recommendations Vivek Patel, Ernesto Jimenez, Lorraine Cornwell, Trung Tran, David Paniagua, Ali E. Denktas, et al. (+5)
51 [GO] 2020―May―16 Cardiovascular Disease Prevention and Implications of COVID-19: An Evolving Case Study in the Crescent City Alexander C. Razavi, Tanika N. Kelly, Jiang He, Camilo Fernandez, Paul K. Whelton, Marie Krousel-Wood, Lydia A. Bazzano
52 [GO] 2020―May―12 COVID-19 and the Cerebro-Cardiovascular Systems: What do we Know so Far? Anthony S. Larson, Luis Savastano, Ramanathan Kadirvel, David F. Kallmes, Ameer E. Hassan, Waleed Brinjikji
53 [GO] 2020―Apr―29 Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors Ajay K. Gupta, Hani Jneid, Daniel Addison, Hossein Ardehali, Amelia K. Boehme, Sanket Borgaonkar, et al. (+18)
54 [GO] 2020―Apr―01 Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? Rami Sommerstein, Michael M. Kochen, Franz H. Messerli, Christoph Gräni
55 [GO] 2020―Apr―01 Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Junyi Guo, Zheng Huang, Li Lin, Jiagao Lv

[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.007 sec